Stifel Maintains Hold on Globus Medical, Lowers Price Target to $80
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsPrice Target
Stifel analyst Tom Stephan maintains Globus Medical (NYSE:GMED) with a Hold and lowers the price target from $95 to $80.
Stifel analyst Tom Stephan maintains Globus Medical (NYSE:GMED) with a Hold and lowers the price target from $95 to $80.